Lina Hohmann
About Lina Hohmann
Lina Hohmann is the Associate Director of Market Access Immunology & Fibrosis at Bristol Myers Squibb in Metropolregion München, with over 7 years of experience in market access and health economics.
Title
Lina Hohmann holds the title of Associate Director of Market Access Immunology & Fibrosis at Bristol Myers Squibb, based in the Metropolregion München.
Current Position at Bristol Myers Squibb
Lina Hohmann currently works at Bristol Myers Squibb as the Associate Director of Market Access Immunology & Fibrosis. She joined the company in June 2020.
Previous Roles at Celgene
Before joining Bristol Myers Squibb, Lina Hohmann held various roles at Celgene. She started as an Associate Manager of Market Access from 2017 to 2018, then progressed to Manager Market Access from 2018 to 2020. Briefly in 2020, she worked as the Disease Area Access Lead.
Education and Academic Background
Lina Hohmann pursued her higher education at Universität zu Köln, where she studied Health Economics. She earned her Bachelor of Science (B.Sc.) degree from 2011 to 2014 and her Master of Science (M.Sc.) degree from 2014 to 2016.
Early Career and Internships
Lina Hohmann began her career with internships and assistant roles that gave her solid foundational experience in health economics. She interned at The Janssen Pharmaceutical Companies of Johnson & Johnson in 2016 and at HGC Healthcare Consulting in 2014. She also gained experience as a Student Assistant at Universität zu Köln and HGC Healthcare Consulting, and completed a Bachelor thesis on health economic modeling.
Experience in Health Economics
With over 7 years of experience in market access and health economics, Lina Hohmann's career includes significant roles and internships at leading organizations like Celgene, HGC Healthcare Consulting, and The Janssen Pharmaceutical Companies of Johnson & Johnson. Her work has consistently focused on the intersection of health economics and market access.